Selective Thromboembolism Prophylaxis After Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

January 1, 2018

Conditions
Venous Thrombosis, DeepArthroplasty Complications
Interventions
DRUG

selective anticoagulation

Selective anticoagulation group used anticoagulant once thromboelastography indicated hypercoagulable state. Conventional anticoagulation group used anticoagulant until one month after surgery routinely. The main difference was that the experimental group did not use anticoagulation if the thromboelastography indicated that the blood coagulation status was normal while the control group use anticoagulation routinely.

All Listed Sponsors
lead

Guangdong Provincial People's Hospital

OTHER

NCT03804697 - Selective Thromboembolism Prophylaxis After Arthroplasty | Biotech Hunter | Biotech Hunter